Eric Wang joins Jackson Laboratory in role to overcome treatment resistance in leukemia

HBJ File Photo The Jackson Laboratory.

Write a Comment

By Robert Storace

The Jackson Laboratory for Genomic Medicine in Farmington has announced that scientist Eric Wang has joined the faculty as an assistant professor with the goal of devising new strategies to overcome the development of drug resistance in cancer.

Wang earned his Ph.D. at the Sackler Institute of Biomedical Science at New York University and joins the Jackson faculty from a postdoctoral fellowship in the laboratory of Omar Abdel-Wahab, director of Memorial Sloan Kettering’s Center for Hematologic Malignancies.

“It has been inspiring for me to watch Eric’s growth as a scientist,” Abdel-Wahab said in a statement. “From his earliest involvement in research at Cold Spring Harbor laboratories to his time as a postdoctoral fellow at Memorial Sloan Kettering Cancer Center, he has been consistently responsible for amazing discoveries in our understanding of leukemia development and generation of new leukemia treatments.”

Wang said in a statement that, while at Jackson Laboratory, he hopes to work on understanding how leukemia cells develop resistance and to work on strategies that will overcome therapy resistance.